HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jaebong Jang Selected Research

Jaebong Jang Research Topics

Disease

6Lung Neoplasms (Lung Cancer)
01/2022 - 01/2016
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2017
4Neoplasms (Cancer)
01/2022 - 11/2019
4Infections
01/2019 - 01/2018
2Prostatic Neoplasms (Prostate Cancer)
06/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
06/2021 - 01/2021
2Dengue (Dengue Fever)
01/2019 - 01/2018
1Cushing Syndrome
07/2023
1Breast Neoplasms (Breast Cancer)
11/2015
1Peritonitis
07/2015
1Edema (Dropsy)
11/2012
1Arthritis (Polyarthritis)
11/2012

Drug/Important Bio-Agent (IBA)

5ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2016
5Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2018
4Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2016
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2016
3Antiviral Agents (Antivirals)IBA
01/2019 - 01/2018
2VaccinesIBA
01/2019 - 01/2019
2Adenosine Triphosphate (ATP)IBA
01/2019 - 01/2016
2AntibodiesIBA
01/2019 - 01/2018
2Anaplastic Lymphoma KinaseIBA
12/2018 - 08/2017
2AfatinibIBA
01/2018 - 01/2016
2ZymosanIBA
07/2015 - 11/2012
1CholesterolIBA
07/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2023
1SteroidsIBA
07/2023
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2023
1SodiumIBA
01/2022
1QuinazolinonesIBA
01/2022
1Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
06/2021
1Gallium-68IBA
06/2021
1Copper-64IBA
06/2021
1AntigensIBA
06/2021
1Fluorine-18IBA
06/2021
1Radioisotopes (Radionuclides)IBA
06/2021
1Serine Proteases (Serine Protease)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1hepsinIBA
01/2021
1Viral Envelope ProteinsIBA
01/2018
1Dengue VaccinesIBA
01/2018
1ceritinibIBA
08/2017
1osimertinibIBA
08/2017
1EAI045IBA
01/2016
1Gefitinib (Iressa)FDA Link
01/2016
1Cetuximab (Erbitux)FDA Link
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Transcription Factors (Transcription Factor)IBA
11/2015
1CryptochromesIBA
11/2015
1CarrageenanIBA
11/2012

Therapy/Procedure

3Therapeutics
01/2022 - 01/2019